Stocks of Oscar Health Inc (NYSE:OSCR) traded higher last session on Wall Street, down -3.14% to $14.19.
OSCR stock price is now -6.47% away from the 50-day moving average and -15.99% away from the 200-day moving average. The market capitalization of the company currently stands at $3.56B.
With the price target of $12, Jefferies recently initiated with Underperform rating for Oscar Health Inc (NYSE: OSCR). On November 06, 2024, BofA Securities Downgraded its previous ‘Neutral’ rating to ‘Underperform’ on the stock reducing its target price from $21 to quote $13.50, while ‘UBS’ rates the stock as ‘Neutral’
In other news, ALESSANDREA QUANE, Former Officer bought 700 shares of the company’s stock on Mar 10 ’25. The stock was bought for $11,551 at an average price of $16.50. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 07 ’25, Former Officer ALESSANDREA QUANE bought 5,101 shares of the business’s stock. A total of $84,181 was incurred on buying the stock at an average price of $16.50. A total of 29.66% of the company’s stock is owned by insiders.
During the past 12 months, Oscar Health Inc has had a low of $12.43 and a high of $23.79. The fifty day moving average price for OSCR is $15.1714 and a two-hundred day moving average price translates $16.89 for the stock.
The latest earnings results from Oscar Health Inc (NYSE: OSCR) was released for 2024-12-31. The net profit margin was 0.28% and return on equity was 2.80% for OSCR. The company reported revenue of $2.39 billion for the quarter, compared to $1.43 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 67.11 percent.
